Oleolive is a biotechnology company founded by scientists dedicated to advancing innovative technology from traditionally overlooked research institutions. The company's core mission is to develop and commercialize oleocanthal, a compound with significant therapeutic potential, for research, supplements, and other novel applications. Oleolive's vision is to transform oleocanthal into a widely accessible therapeutic agent through their patent-pending scalable extraction method, positioning them at the forefront of this niche market.

Notable individuals affiliated with Oleolive include a team of deep subject matter experts who collaborate with institutional researchers to drive forward medical technologies. The company has achieved significant milestones, such as the development of their proprietary extraction technology for oleocanthal. Oleolive's impact lies in its potential to revolutionize the use of oleocanthal in various therapeutic areas, contributing to more efficient drug development and offering new solutions for challenging health conditions.